B
Bryan Burmeister
Researcher at Princess Alexandra Hospital
Publications - 163
Citations - 8693
Bryan Burmeister is an academic researcher from Princess Alexandra Hospital. The author has contributed to research in topics: Radiation therapy & Chemoradiotherapy. The author has an hindex of 39, co-authored 158 publications receiving 7908 citations. Previous affiliations of Bryan Burmeister include Sir Charles Gairdner Hospital & University of Queensland.
Papers
More filters
Journal ArticleDOI
Refining esophageal cancer staging after neoadjuvant therapy: importance of treatment response
Andrew Barbour,Mark Jones,Mithat Gonen,David C. Gotley,Janine Thomas,Damien Thomson,Bryan Burmeister,B. Mark Smithers +7 more
TL;DR: The current AJCC staging system for esophageal cancer is inadequate for patients that receive neoadjuvant CRT andRefinement of the AJ CC staging system should include primary tumor response for patients receiving neoadedjuvantCRT.
Journal ArticleDOI
Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04).
Nabila Ansari,Michael J. Solomon,Richard Fisher,John Mackay,Bryan Burmeister,Stephen P. Ackland,Alexander G. Heriot,David Joseph,Sue-Anne McLachlan,Sue-Anne McLachlan,Bev McClure,Samuel Y Ngan +11 more
TL;DR: LC had significantly higher AEs compared with SC with no statistically significant differences in postoperative complications and there were clinical trends in permanent stoma rates and anastomotic leaks in favor of LC but with an increased perineal wound breakdown rate.
Journal ArticleDOI
Radiation therapy for nodal disease in malignant melanoma.
Bryan Burmeister,Bernard Mark Smithers,Michael Poulsen,G R McLeod,G. Bryant,Lee Tripcony,C. Thorpe +6 more
TL;DR: There is a need for additional studies with the use of adjuvant radiation therapy following therapeutic lymph node dissection for inoperable metastatic malignant melanoma patients.
Journal ArticleDOI
Adjuvant Whole-Brain Radiation Therapy Compared With Observation After Local Treatment of Melanoma Brain Metastases: A Multicenter, Randomized Phase III Trial
Angela Hong,Angela Hong,Gerald B Fogarty,Gerald B Fogarty,Kari Dolven-Jacobsen,Bryan Burmeister,Serigne Lo,Serigne Lo,Lauren E. Haydu,Janette L. Vardy,Janette L. Vardy,Anna K. Nowak,Haryana M. Dhillon,Tasnia Ahmed,Brindha Shivalingam,Brindha Shivalingam,Brindha Shivalingam,Georgina V. Long,Georgina V. Long,Alexander M. Menzies,Alexander M. Menzies,George Hruby,George Hruby,George Hruby,Katharine J. Drummond,Katharine J. Drummond,Catherine Mandel,Mark R. Middleton,Claudius H Reisse,Elizabeth J. Paton,Victoria Steel,Narelle Williams,Richard A. Scolyer,Richard A. Scolyer,Rachael L. Morton,John F. Thompson,John F. Thompson +36 more
TL;DR: After local treatment of one to three melanoma brain metastases, adjuvant WBRT does not provide clinical benefit in terms of distant intracranial control, survival, or preservation of performance status.
Journal ArticleDOI
Whole brain irradiation following surgery or radiosurgery for solitary brain metastases: mature results of a prematurely closed randomized Trans-Tasman Radiation Oncology Group trial (TROG 98.05).
Daniel E. Roos,Andrew Wirth,Bryan Burmeister,Nigel Spry,Katharine J. Drummond,Jennifer Beresford,B. McClure +6 more
TL;DR: The results are not inconsistent with two larger randomized trials and support the use of upfront WBI to decrease brain recurrence in this setting.